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Daniel G. Clair, MD,d Auckland, New Zealand; Santiago, Chile; and Cleveland, Ohio
Objective: Customized fenestrated endovascular stent grafts have been investigated as an alternative to open surgery for
repair of more complex juxtarenal aortic aneurysms (JAAs). The substantial time required to design and manufacture
these devices has led to the desire for a standardized fenestrated endovascular system. We report the initial pilot study
results of a potential “off-the-shelf” fenestrated device system to assess its initial safety and feasibility for endovascular
repair of JAAs and pararenal aortic aneurysms (PAAs).
Methods: Following ethics committee approvals, consenting patients were evaluated for eligibility. Patients with aneurysms
abutting or including the renal artery oriﬁces who were not candidates for standard infrarenal endograft placement
because of proximal aortic neck morphology were further assessed for anatomic suitability for this “off-the-shelf” device.
There were a number of anatomic requirements, the most important being a stable infra-superior mesenteric artery aortic
neck length$15 mm. Patients are assessed in-hospital and in follow-up at 1, 6, and 12 months, and annually thereafter to
5 years for adverse events and using contrast-enhanced computed tomography angiography with Core Laboratory
interpretation of renal perfusion, device integrity, migration, endoleak, and aneurysm morphology.
Results: Fifteen patients (87% male) with JAAs (93%) or PAAs (6.7%) presented at mean age of 77 years (range, 66-85
years) and with mean sac diameter of 5.9 cm (range, 5.1-7.9 cm). Four Ventana fenestrated stent graft models having
aligned fenestrations (three models) or offset fenestrations (one model) and renal stent grafts were successfully implanted
among the patients, and all renal and visceral arteries were preserved. Mean endovascular procedure time was 108 minutes
(range, 71-212 minutes) with mean contrast usage and ﬂuoroscopy time of 254 mL (range, 67-420 mL) and 55 minutes
(range, 27-104 minutes), respectively. Five patients received blood products. Mean time to hospital discharge was 3.3
days (range, 2-9 days). In follow-up to 6 months and 1 year, no rupture, conversion to open repair, migration, type I/III
endoleak, or renal loss/infarcts were observed. Two late nonaneurysm-related deaths have occurred. One secondary
procedure for iliac limb kinking/occlusion and one secondary procedure for renal artery stenosis have been performed.
Conclusions: Early experience supports procedural and initial postprocedural safety and demonstrates proof of concept for
the off-the-shelf Ventana fenestrated system for the endovascular repair of JAAs and PAAs in selected patients. Continued
follow-up and expanded multicenter clinical experience is warranted. (J Vasc Surg 2013;57:1235-45.)3,4Endovascular repair of infrarenal abdominal aortic
aneurysm (AAA) in patients with suitable nonaneurysmal
proximal neck and distal anatomy is shown to reduce peri-
operative morbidity and mortality compared with open
surgical repair.1,2 Anatomic unsuitability for standard
endovascular AAA repair is reported in 35% to 45% of
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://dx.doi.org/10.1016/j.jvs.2012.10.125unfavorable infrarenal neck anatomy. Attempts to extend
the application of standard endografts to anatomies outside
of the clinically tested parameters, including a short prox-
imal seal zone length, have been reported to increase the
risk of device failure manifested as clinically signiﬁcant
migration, type I or III endoleak, and aneurysm rupture.5,6
To address this limitation, a patient-customized fenestrated
endograft designed for short infrarenal neck (juxtarenal)
aortic anatomy has been used. Published results report
favorable outcomes in selected patients.7,8 However,
because substantial time is required for the individual plan-
ning, manufacture, and delivery of these devices, there
remains an unmet need for a standardized, readily available
off-the-shelf endograft system for repair of more complex
aortic aneurysm anatomies.
This article reports the initial results from the ﬁrst
prospective pilot study of the Ventana fenestrated system
(Endologix Inc, Irvine, Calif).
METHODS
Study design. A prospective, single-arm pilot study
(NCT01437215) of the Ventana fenestrated system was
conducted at two centers in Chile and New Zealand having1235
Fig 1. Anatomic illustration of the implant. Note the bifurcated
unibody stent graft (short arrow), anatomically ﬁxed at the aortic
bifurcation; Ventana fenestrated/scalloped proximal extension
stent graft (long arrow); Xpand renal stent grafts (arrowheads).
Fig 2. Ventana stent graft system ﬂuoroscopic image. The Ven-
tana stent graft is constrained within its delivery system, which is
advanced through a deployed bifurcated stent graft (arrowhead).
Note the “U” shaped radio-opaque marker outlining the visceral
scallop (short arrows) and the right and left fenestration circum-
ferential markers (long arrows). Front sheath, outer sheath, and
renal guide sheath markers are also visible.
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surgical repair, and visceral artery interventional techniques.
An initial case report from this experience is available.9 This
is the ﬁrst human clinical use of the device system; accord-
ingly, this study is intended to determine whether expanded
clinical investigation is warranted. Each site obtained local
approval for human investigation, and written patient
informed consent was obtained. The primary safety assess-
ment is the incidence of major adverse events (MAEs) at 30
days. MAEs include all-cause mortality, bowel ischemia,
myocardial infarction, paraplegia, renal failure, respiratory
complication, stroke, and blood loss $1000 mL. The
primary feasibility assessment is successful device delivery
and deployment, with endograft patency and absence of type
I/III endoleak at 30 days. Other assessments include core
laboratory evaluations of computed tomography (CT)
scans; renal function via estimated glomerular ﬁltration rate
(eGFR); and distal perfusion evaluation via ankle-brachial
index (ABI) determination.
Device description. The Ventana fenestrated system
consists of the commercially available bifurcated stent
graft, the Ventana fenestrated proximal extension stent
graft, and the Xpand renal stent grafts (Endologix Inc)
(Fig 1). The bifurcated device is a unibody self-expanding
cobalt chromium alloy endostent with an expanded
polytetraﬂuoroethylene (ePTFE) graft attached proximally
and distally using surgical suture. The stent graft is con-
strained within a catheter-based delivery system. The
Ventana fenestrated stent graft has the same stent elements
as the bifurcated stent graft. Its ePTFE graft is continuous,
incorporating an oversized midsection having two 3-mm
diameter fenestrations. There is no stent interference with
the fenestrations. The proximal stent graft segment varies
in diameter from 24 to 38 mm depending upon model and
is ePTFE covered except for a 4-cm-length anterior bare
stent scallop intended to encompass the superior mesen-
teric artery (SMA) and celiac arteries. The 28-mm diameter
distal stent graft segment is intended to attain substantial
overlap with the bifurcated stent graft body. Radiopaque
markers identify the proximal scallop margins and the
fenestrations circumferentially (Fig 2). The fenestrations
are expandable to 10 mm in diameter and are movable in
situ longitudinally and circumferentially to accommodate
a wide range of renal artery anatomies. Sizing of this device
is relative to the length and diameter of the nonaneurysmal
aorta immediately inferior to the SMA, relative locations of
the visceral arteries, and aortic length. A total of 24 models
are indicated for neck diameters of 18 to 34 mm, with eight
having aligned fenestrations (renal arteries spaced longitu-
dinally 6 15 mm) and 16 having offset fenestrations (renal
arteries spaced >15-30 mm, with either left or right
fenestration superior). The delivery system (Fig 3) has 22F
outer diameter proﬁle, incorporating 6.5F guide sheaths
preloaded through the fenestrations for rapid renal artery
cannulation and stent graft delivery. Fenestration pushers
are short segments of hollow tubing that ride over the renal
guide sheaths with a monorail handle, which permit the
operator to advance the fenestrations to and/or into therenal artery as desired. The Xpand renal stent graft consists
of a premounted balloon-expandable cobalt chromium
alloy endostent with an ePTFE graft cover, intended for
renal artery lumen diameters of 4 to 8 mm. The most
proximal 5 mm is designed to protrude from the
Fig 3. Ventana delivery system user interface. The central handle
is bounded on the left and right by the 6.5F guide sheaths (long
arrows) and fenestration pushers (short arrows).
Fig 4. Initial renal artery cannulation. A downward-seeking
catheter (long arrow) has been introduced through the right renal
sheath allowing cannulation of the right renal artery. Note the
control pigtail catheter introduced from the contralateral femoral
artery (short arrow). Angiographic catheters with guidewires (black
arrows) are advanced into renal artery ostia.
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a separate balloon.
Device delivery and deployment. Following bilateral
vascular access, a 12F tear-away introducer sheath is
inserted into the ipsilateral femoral artery and a 9F intro-
ducer sheath is inserted contralaterally. The commercially
available 25-mm bifurcated device is selected such that the
proximal edge of the anatomically ﬁxed body is 1 to 3 cm
below the most caudal renal artery after implant, and limbs
are of suitable diameter (available range, 13-16 mm) and
length (available range, 30-55 mm) to preserve at least one
hypogastric artery. Bifurcated device implant steps have
been previously described.10 After deployment, the delivery
system is removed. The Ventana delivery system is then
inserted ipsilaterally over the .035-inch guidewire; a
compliant balloon may be inﬂated in the contralateral limb
of the bifurcated device to maintain its secure positioning
during delivery system advancement. The system is
advanced through until the radiopaque markers on the
ends of the 6.5F sheaths are visualized approximately 1 to 2
cm below the lowest renal artery. Retraction of the delivery
system handle exposes the 6.5F sheaths while constraining
the proximal and distal segments of the fenestrated stent
graft. An angiographic catheter and guidewire (.035 inch
or smaller) is inserted into each 6.5F sheath and tracked for
renal artery cannulation (Fig 4). While pinning each
angiographic catheter, the corresponding 6.5F sheath is
advanced over the angiographic catheter and into the renal
artery (Fig 5). The Ventana delivery system is then ad-
vanced, and the central radiopaque marker of the SMA
scallop aligned several millimeters above the SMA (Fig 6).
The SMA scallop side radiopaque markers are also visual-
ized in the frontal projection (Fig 7, A). Once the proper
alignment is veriﬁed, the pusher rod is advanced to deploy
the Ventana proximal segment. The system can then be
retracted caudally so the SMA and celiac artery are within
the boundaries of the scallop (Fig 7, B). Retraction of the
outer sheath deploys the Ventana distal segment within the
bifurcated stent graft body (minimum overlap, 3 cm). In
patients with long or tortuous infrarenal anatomies or at
physician discretion, a standard infrarenal extension can be
placed at the junction of the bifurcated and Ventana stent
grafts. The fenestration pushers are used to advance thefenestrations to the renal ostia. Balloon dilatation of
attachment sites is performed if desired. After removal of
the angiographic catheters placed within the renal arteries,
the renal stent grafts (oversized 5%-20% relative to the
artery lumen diameter) are advanced over the guidewires
through the renal sheaths (Fig 8) and positioned with
approximately 5 mm length protruding into the aorta. The
remaining lengths extend through the fenestrations into
the renal arteries. The stents are expanded and the angio-
plasty balloons removed.
Subsequently, a separate angioplasty balloon (8-10 mm
diameter) is advanced through each 6.5F sheath and used
to ﬂare the aortic renal stent graft segments. Angiographic
imaging in both lateral and anterior-posterior projections is
conducted to ascertain device position, apposition to the
aortic wall, vessel patency, and absence of endoleaks
(Fig 9). The delivery system and guidewires are then
removed, and closure of the groins performed in usual
fashion.
Patient and device selection. Patients with juxtarenal
aortic aneurysms (JAAs) or pararenal aortic aneurysms
(PAAs) (Table I) underwent high-resolution CT angiog-
raphy and clinical baseline evaluations. Core Laboratory
(Cleveland Clinic Peripheral Vascular Laboratory, Cleve-
land, Ohio) and independent physician (D.C.) analyses of
CT scans determined anatomic eligibility. Devices were
selected based on these anatomic measurements. The
fenestrated device was selected to allow 10% to 20%
Fig 5. Renal guide sheath advancement. After successful renal
artery cannulation, 6.5F renal guide sheaths are advanced into
each renal artery.
Fig 6. Proximal scallop to superior mesenteric artery (SMA)
alignment. The central scallop marker (arrow) is oriented a few
millimeters above the base of the SMA as viewed in a lateral
projection. The scallop can be lowered into optimum position after
the proximal graft segment has been deployed.
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extensions were selected per physician discretion.
Follow-up evaluations. Prior to hospital discharge,
patients underwent a physical examination, blood labora-
tory evaluations (serum creatinine, blood urea nitrogen,
hematocrit, and hemoglobin), and ABI determinations.
Protocol-speciﬁed continued follow-up is at 1 and 6
months and annually to 5 years. At each visit, clinical
evaluations and contrast-enhanced CT scan analyses with
core laboratory assessment are conducted. All patients
completed 1-month follow-up (Fig 10); eight patients have
reached 6-month follow-up; and three patients have
reached 1-year follow-up. Paired comparisons of propor-
tions and of continuous variables were assessed using Fisher
exact test and two-sided t-test, respectively.
Deﬁnitions and data analysis. JAA is an aneurysm
encroaching upon but not involving the renal arteries.
PAA is an aneurysm involving one or both of the renal
arteries. Endoleak is the presence of contrast material
within the aneurysm sac and outside of the graft material.
Migration is >10 mm movement of the infra-SMA edge
of the stent graft. Renal failure is an increase in serum
creatinine >0.5 mg/dL on two consecutive assessments, or
need for temporary or permanent dialysis. Renal dysfunc-
tion is a reduction in eGFR >30% from baseline. Respira-
tory complication is pneumonia or need for intubation after
24 hours postprocedure.
RESULTS
Enrollment and procedural outcomes
Two sites screened 23 patients, with eight screen fail-
ures attributable to inadequate infra-SMA neck, renal ostialstenosis >70%, or severe proximal neck angulation. The
remaining 15 patients were enrolled between November
2010 and August 2011 (New Zealand, eight; Chile, seven),
with continuing follow-up for all patients scheduled through
5 years. Baseline characteristics are shown in Table II
(demographics and risk factors) and Table III (anatomic
characteristics). Enrolled patients included 13 males (87%)
and two females (13%) with mean age of 77 years and
comorbidities typical of this population. The mean aneu-
rysm sac diameter was 5.9 cm (range, 5.1-7.9 cm). All
patients had an infrarenal neck length <15 mm (mean,
6.9 mm; range, 0-14 mm). Spacing of the renal arteries
was 0 to 18mm longitudinally and 122 to 204 (clockface).
Per the Society for Vascular Surgery reporting stan-
dards,11 procedural technical success was achieved in
100% of patients. Anesthesia selection was general (80%)
or regional (20%). Bifurcated stent grafts used in the study
had 22 or 25 mm aortic body diameter with length 80 or
100 mm (total length 120 or 140 mm). Four Ventana stent
grafts were used; 14 patients received the device with
aligned fenestrations (24 mm [n ¼ 4]; 28 mm [n ¼ 9];
32 mm [n ¼ 1]). One patient having renal arteries longitu-
dinally spaced 18 mm received the 32-mm fenestrated
device with the left superior fenestration. One patient with
a long and tortuous infrarenal aorta received an infrarenal
extension at the junction of the bifurcated and Ventana
stent grafts to provide added stability. Three patients
Fig 7. Deployed proximal segment of Ventana stent graft. A, Frontal projection: The radiopaque markers along
the sides of the visceral artery scallop (arrows). B, Lateral projection: The graft has been retracted caudally to position
the radiopaque marker at the base of the visceral artery scallop immediately below the superior mesenteric artery
(SMA) (arrow).
Fig 8. Xpand renal stent graft catheter placement. The most
proximal 5 mm of the renal stent graft remains in the aorta for
ﬂaring (arrows).
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procedure and received limb extensions. Because of the
timing of product availability, the ﬁrst ﬁve patients enrolled
received Advanta V12 covered stents (Atrium Medical,
Hudson, NH) to maintain the patency of the renal arteries;
the last 10 patients received the Xpand device.
Mean ﬂuoroscopy time was 55 minutes (range, 27-104
minutes), and mean contrast volume was 254 mL (range,
67-420 mL). From initial bifurcated system introduction,
the mean time to complete renal artery cannulation was40 minutes. In one patient having a highly tortuous right
renal artery and a sharply downward posterior geometry
on the left, difﬁculties in renal artery cannulation were
encountered that required several angiographic catheter
and guidewire exchanges (Fig 11). A mild renal artery
dissection occurred because of the manipulations, which
spontaneously resolved at 1 month. The mean (range)
of endovascular procedure time, total (skin to skin)
procedure time, and anesthesia time were 108 minutes
(range, 71-212 minutes), 211 minutes (range, 130-377
minutes), and 244 minutes (range, 153-398 minutes),
respectively. Mean estimated blood loss was 628mL (range,
200-1500 mL); ﬁve patients received blood products.
Patients were discharged from the hospital at a mean of
3.3 days (range, 2-9 days). In evaluation of the renal cannu-
lation time, ﬂuoroscopy time, and endovascular procedure
time (Table IV) among the last ﬁve patients compared
with the ﬁrst 10 patients treated, a trend toward reduced
times appears suggestive of a learning curve.
Procedural complications. In one patient having
highly calciﬁed access vessels, an ipsilateral femoral artery
localized dissection occurred, leading to distal occlusion
observed while in recovery. Immediate vessel repair via
femoral endarterectomy and patching was performed. No
thrombosis or limb ischemia was observed, and ABI was
improved at 1 month. Other complications attributed to
the procedure include hematoma development at the
access site, resolved spontaneously (n ¼ 2); and minor
renal artery dissection attributable to angiographic cath-
eter/guidewire manipulation, resolved intraoperatively
with angioplasty (n ¼ 1) or not treated (n ¼ 1). Both renal
artery dissections occurred early in the study and in
Fig 9. Final angiographic runs. A, Lateral projection showing a patent superior mesenteric artery (SMA). B, Frontal
projection shows the oversized graft (arrows) in the visceral segment creating extended seal zones with the aortic
anatomy.
Table I. Patient selection criteria
d Iliac/femoral artery access vessel diameter compatible with
delivery systems
d Renal arteries with length $13 mm and without signiﬁcant
occlusive disease (<70% stenosis)
d Absence of essential accessory renal artery (ie, one that
supplies >25% of the renal parenchyma)
d Mural thrombus in suprarenal segment #5 mm in thickness
over #60% of circumference
d Infrarenal neck length <15 mm
d Nonaneurysmal proximal neck relative to the SMA with
length $15 mm, diameter 18 to 34 mm, and angle to the
aneurysm sac #60
d Renal arteries with reference diameters of 4 to 8 mm, that are
0 to 35 mm below the SMA, and within each other 6 30 mm
(longitudinally) and 90 to 210 (clockface)
d Celiac artery to SMA angle #60 (clockface)
d SMA to aortoiliac bifurcation length $90 mm
d Common iliac artery diameter 10 to 23 mm with seal zone
length $15 mm
d Ability to preserve at least one hypogastric artery
d Fenestrated stent graft overlap with bifurcated stent graft
$3cm
SMA, Superior mesenteric artery.
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not been residual sequelae to current follow-up.
Primary study assessments
MAEs. Procedurally to within 30 days (Table V), no
death occurred. Blood loss >1000 mL with transfusion
occurred in two patients (13%). One patient with localized
access vessel dissection described above underwent vessel
repair, and in the other, a delivery system valve hub was
inadvertently broken, and a delivery system exchange was
done to place an infrarenal extension at the bifurcated-
fenestrated stent graft junction. Both patients were dis-
charged in satisfactory condition.Clinical success. All endovascular procedures were
completed successfully. Core Laboratory evaluations of
CT scans revealed stable, properly placed devices without
type I or III endoleak at 1 month. One patient (6.7%)
reporting claudication postdischarge underwent magnetic
resonance imaging on day 21 revealing right external iliac
artery occlusion because of a kink in the bifurcated device
right limb and high grade stenosis on the left side. Femoral
to femoral bypass with stent placement was performed on
day 26 to resolve the ﬁndings. Upon re-review of the
intraoperative angiography, the bifurcated limb device kink
was present but not recognized at the time.
Additional assessments
Late MAEs. After 30 days and to current follow-up
(Table V), two nonaneurysm-related deaths have occurred
(13%). One was due to subdural hematoma and cerebral
hemorrhage secondary to a witnessed accidental fall at 3.3
months postoperatively. The other was due to left parietal
intracerebral hemorrhage at 5.7 months postprocedure in
a patient with chronic atrial ﬁbrillation. No other late MAEs
have occurred.
Other adverse events. Two patients developed post-
procedural groin hematomas that spontaneously resolved.
One patient developed in-hospital urosepsis requiring
intravenous antibiotics; she also developed atrial tachy-
cardia secondary to the infection. Both resolved prior to
her discharge from the hospital on postoperative day 8.
Renal function. Compared with preoperative values,
mean eGFR values are similar at 1 month (60 vs 58
[n ¼ 15]) and 6 months (56 vs 52 [n ¼ 8]). Renal function
has been well maintained in these patients, with no renal
infarcts observed.
Distal perfusion. Compared with preoperative values,
mean ABI are similar at 1 month (1.05 vs 1.03 [n ¼ 15])
Fig 10. Examples of preoperative and 1-month case computed tomography (CT) images. SMA, Superior mesenteric
artery.
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well maintained.
Device integrity. The Core Laboratory assessed CT
scans to evaluate device integrity and to determine the inci-
dence of stent fracture, graft fatigue/failure, migration,
limb occlusion, and renal stenosis/occlusion. No stent frac-
tures, graft fatigue/failures, or migrations have been
observed. No aneurysm rupture or conversion to open
repair has occurred. One limb occlusion was repaired as
noted above. One patient is identiﬁed with late bilateral
renal artery stenoses at the distal junctions with the
implanted 5-mm renal stent grafts attributed to implant
of undersized renal stent grafts at the index procedure.
The stenoses were successfully resolved with implantation
of 7-mm Precise stents (Cordis Corporation, Miami
Lakes, Fla).
Endoleaks and sac morphology. Core Laboratory
assessment revealed no type I, type III, or type IV endoleaks
through current follow-up. Three patients (20%) were
identiﬁed with mild type II endoleaks at 1 month that are
continuing at 6 months. Through current follow-up, all sac
diameters are stable or decreasing, and no secondary
procedure for endoleak has been performed.
DISCUSSION
Open surgical repair of more complex JAAs or PAAs
requires suprarenal or supraceliac aortic clamping and
eventual renal artery reconstruction, leading to renal
ischemia and increasing the risk of mortality andmorbidity, including bleeding, renal failure, and associated
sequelae compared with infrarenal aortic aneurysm
surgical repair.12,13 As such, efforts have been made to
develop potential options to extend the perioperative
beneﬁts observed following endovascular stent graft repair
of infra-renal aneurysms14 to these more complex aortic
aneurysms. Multicenter studies of one patient-customized
fenestrated stent graft used in conjunction with various
bare or covered stents have demonstrated positive
outcomes.7,8 Encouraging initial experience among eight
patients with another patient-customized fenestrated
endograft has been made available.15 Access to these
custom fenestrated devices has been limited to selected
centers because of the substantial time required for custom
device planning and manufacture, technical challenges of
custom device deployment, and the ability of centers to
support customized technology with adequate training
and resources.16 In the most recent meta-analysis of
custom fenestrated endografting of JAAs and PAAs from
2001 to 2010 (n ¼ 629), Linsen and colleagues16 reported
a pooled estimate for technical success of 90.4%, and
pooled estimates of 93.2% for branch vessel patency,
22.2% for renal impairment, and 17.8% for secondary inter-
vention in follow-up ranging from 15 to 25 months. More
recently, a retrospective analysis of 100 patients treated
with a custom fenestrated endograft at a single center
found that 72% could theoretically be treated by one of
two standardized model designs having more ﬂexible
fenestration elements.17 The availability of published
Table II. Baseline demographics and comorbidities
Characteristic Result
Male sex 13 (87)
Age, years 77 6 5.6
Serum creatinine, mg/dL 1.2 6 0.2
Arrhythmia 5 (33)
Cerebrovascular disease 1 (6.7)
Coronary artery disease 1 (6.7)
Chronic obstructive pulmonary disease 3 (20)
Diabetes 4 (27)
Gastrointestinal abnormality 2 (13)
Hypertension 12 (80)
Hypercholesterolemia 12 (80)
Peripheral arterial disease 1 (6.7)
Prior abdominal surgery 3 (20)
Prior myocardial infarction 2 (13)
Prior coronary artery bypass grafting 1 (6.7)
Renal failure 1 (6.7)
Smoking (ever) 9 (60)
Results reported as n (% of 15) or mean 6 standard deviation.
Table III. Preoperative aneurysm and vascular anatomy
Characteristic Result
JAA/PAA 14 (93)/1 (6.7)
Aneurysm sac diameter, cm 5.9 6 0.8
Infra-SMA proximal neck diameter, mm 24 6 2.2
Aortoiliac bifurcation diameter, mm 29 6 9.4
Infra-SMA proximal neck length, mm 25 6 9.9
Infrarenal proximal neck length, mm 6.9 6 5.3
SMA to aortoiliac bifurcation length, mm 144 6 13
Left renal artery diameter, mm 5.9 6 0.7
Right renal artery diameter, mm 5.7 6 0.8
Left to right renal artery length (axial), mm 6.9 6 5.6
Left to right renal artery angle (clockface),  147 6 23
SMA to celiac artery angle (clockface),  17 6 11
SMA to aorta angle,  56 6 14
Proximal neck to aneurysm sac angle,  36 6 15
Ipsilateral external iliac artery diameter, mm 9.3 6 1.5
JAA, Juxtarenal aortic aneurysm; PAA, pararenal aortic aneurysm; SMA,
superior mesenteric artery.
Results reported as n (% of 15) or mean 6 standard deviation.
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analysis.
A prospective clinical study was conducted to evaluate
the initial safety and feasibility of the Ventana fenestrated
system as a potential ‘off the shelf’ option for the endovas-
cular repair of JAA/PAA. Notably, this is the ﬁrst study
conducted using this device conﬁguration, which builds
on the anatomic ﬁxation/proximal sealing technique estab-
lished for the repair of infrarenal aortic aneurysms.10,14 The
main body stent graft seated at the aortic bifurcation
provides columnar support for the larger fenestrated prox-
imal extension stent graft. Because migration forces act
predominantly on the stent graft bifurcation,18 this implant
algorithm takes advantage of the aortic anatomy to attain
secure ﬁxation to resist natural migration forces. Seal is
achieved distally at the junction of the bifurcated stent graft
limbs and common iliac arteries, and proximally at the
junctions of the fenestrated stent graft with the infra-
SMA aorta and fenestrations with the covered renal stents.
A unique feature of this implant design is the visible exten-
sion of proximal seal below the scallop because of the effect
of the conformable graft, which acts independently from
the stent (Fig 10). Nonetheless, severe neck angulation
and clinically signiﬁcant renal artery ostial stenoses limit
the application of any endovascular device design. Proper
device selection as well as placement of the scallop at the
base of the SMA is important to achieving both seal and
maintaining visceral artery patency.
A major advantage of this device system is the cannula-
tion of the renal arteries using preloaded guide sheaths
whereas the fenestrated stent graft proximal and distal
segments remain fully constrained within the delivery
system. All necessary angiographic and guidewire ex-
changes occur through the indwelling guide sheaths of
the Ventana system. Once renal cannulation is achieved,
Ventana proximal and distal deployments are completed.
Integrated fenestration pushers facilitate fenestrationmovement at and into the renal artery oriﬁce, essentially
creating the basis for a branched graft implant. Thereafter,
renal stent graft advancement through the guide sheaths
followed by balloon expansion and ﬂaring in the aortic
segment completes the repair. Moore and colleagues sug-
gested that the rigidity of a balloon-expandable covered
renal stents may lead to difﬁculties in advancement into
the visceral artery.19 These authors furthermore expressed
concern that a covered renal stent implant could result in
suboptimal aortic ﬂaring, potentially leading to poor seal
with the fenestrated stent graft. We did not observe these
particular difﬁculties, likely because of the ﬂexibility of
the integrated guide sheaths, the signiﬁcant range of
motion of the Ventana fenestrations (which have no stent
constraints or interference), and the design of the renal
stent grafts. Flaring in the aorta after renal stent graft
implant was not complex.
Perioperatively and to current follow-up, no aneurysm-
related mortality, aneurysm rupture, or conversion to open
repair occurred. Procedural complications and MAEs were
limited. Considering the complexity of these endovascular
repairs, clinical utility outcomes were reasonable. Even
with this early experience, a limited learning curve was
identiﬁed, which bodes well for further physician training
on this device conﬁguration. Opportunities for improve-
ment exist in delivery system hemostatic component
design, handling, and operating techniques to reduce blood
loss.
Treatment success was achieved. One limb occlusion
observed because of a bifurcated device limb kink was
resolved surgically. A secondary procedure to resolve renal
stenoses in a patient at 6 months underscores the need for
adequate oversizing of the covered renal stent to the renal
artery lumen diameter.
The design of the Ventana fenestrated stent graft orig-
inated based upon a detailed retrospective review of CT
scans from the Endologix infrarenal trial patient cohort.
Fig 11. Challenging renal cannulation example. A, Preoperative computed tomography (CT) anatomy in the oblique
and posterior projections (note the tortuous left renal artery [arrow]). B, Intraoperative arteriography of the renal
arteries showing the irregular, downward pointing right renal artery and the tortuous left renal artery (arrows).
C, Completion angiogram.D, CT at 1 month showing conformance of the oversized graft midsection to the anatomy.
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to determine the range of geometries between the SMA,
celiac, and renal arteries. This analysis yielded a mean renal
to renal (clockface) angle of 151; mean SMA to renal
(clockface) angle of 79; and mean SMA to renal artery
length of 17 mm. More than 85% of the anatomies were
observed with #15 mm renal to renal longitudinal length;
#35 mm SMA to bilateral renal artery length; and 90 to
210 renal to renal clockface angle. These are the design
constraints of the Ventana fenestrated stent graft, suggest-
ing that broad anatomic applicability is anticipated. The
case planning that is required for this device system is
more involved than the infrarenal device; however, the
same principles apply, making this far easier than the plan-
ning required for a customized device. High-resolution CT
scans ranging throughout the anatomic treatment area are
essential to ensuring suitable anatomy for proper device
selection. Focus is placed on the diameter, length, and
quality of the infra-SMA nonaneurysmal neck, SMA tobifurcation length, orientation of the visceral arteries (renal
to renal clockface orientation and longitudinal spacing;
renal to SMA length, SMA to celiac artery clockface orien-
tation), and to a large extent, renal artery quality, length,
and angulation/tortuosity. Because the bifurcated device
serves as the foundational platform and has substantial
overlap with the fenestrated device, size selection is simpli-
ﬁed to essentially the bifurcated device limb length
required to preserve at least one hypogastric artery. The
signiﬁcant range of motion afforded by the movable fenes-
trations within the conformable graft mid-segment
(90-210) and the limited number of devices necessary
to cover the full range of proximal diameters supports its
‘off the shelf ’ characterization. The use of a single Ventana
device in nine patients, with only four models used among
15 patients, 93% of which utilized the aligned fenestration
conﬁguration, supports the concept of this design. None-
theless, the need for a healthy infra-SMA proximal sealzone
cannot be overemphasized to ensure device stability in the
Table IV. Procedural and in-hospital measures
Parameter
First 10
patients
Last 5
patients
All
patients
Fluoroscopy time,
minutes
59 6 26 48 6 11 55 6 22
Contrast volume,
mL
273 6 104 216 6 171 254 6 127
Blood loss, mL 508 6 367 870 6 399 628 6 405
Blood products,
% of patients
30% 40% 33%
Renal artery
cannulation time,
minutesa
45 6 20 31 6 9.6 40 6 18
Endovascular
procedure time,
minutesb
116 6 40 90 6 18 108 6 36
Total procedure
time, minutesc
201 6 39 232 6 86 211 6 58
Anesthesia time,
minutes
244 6 41 226 6 32 238 6 38
Time to hospital
discharge, days
3.4 6 2.9 3.0 6 1.7 3.3 6 2.5
Results shown as % or mean 6 standard deviation.
aTime from initial bifurcated stent graft delivery system introduction to
completion of bilateral renal cannulation.
bTime from initial bifurcated stent graft delivery system introduction to
guidewire removal.
cSkin to skin time.
Table V. MAEs
MAEa
0-30 days,
No. (%)
>30 days,
No. (%)
Total,
No. (%)
Patients with $1 event 2 (13) 2 (13) 3 (20)
Mortality 0 2 (13) 2 (13)
Bowel ischemia 0 0 0
Myocardial infarction 0 0 0
Paraplegia 0 0 0
Renal failure 0 0 0
Respiratory failure 0 0 0
Stroke 0 0 0
Blood loss $1000 cc 2 (13) 0 2 (13)
MAE, Major adverse event.
Results shown as number of patients with event (% of 15).
aDeﬁned as all-cause death, bowel ischemia, myocardial infarction, paraplegia,
renal failure, respiratory complication, stroke, and blood loss of >1000 mL.
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endovascular stent graft system to these more complex
aneurysms was shown among teams with substantial
infrarenal endografting experience, technical skill in visceral
interventional techniques, and suitable facilities with ﬁxed
imaging. A learning curve was identiﬁed, reinforcing the
need for system-speciﬁc training including patient selec-
tion, case planning and device selection, and procedural
techniques.
CONCLUSIONS
This report shows the initial safety, feasibility, and
applicability of the Ventana fenestrated system as an ‘offthe shelf ’ option for the endovascular repair of more
complex JAA/PAA. Further experience and continued
long follow-up will assess durability. Clinical validation in
a broader multicenter trial is warranted.AUTHOR CONTRIBUTIONS
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Submitted Jul 26, 2012; accepted Oct 10, 2012.INVITED COMMENTARYAhmed M. Abou-Zamzam Jr, MD, Loma Linda, CalifHolden et al describe the initial series of patients treated with
a new endovascular platform termed the Ventana by Endologix
(Irvine, Calif). This investigational platform allows the treatment
of aneurysms with short or absent infrarenal necks (juxtarenal or
pararenal aneurysms). As surgeons have become more aggressive
with endovascular aneurysm repair, the true anatomic “noncandi-
dates” have been disappearing. Although technology has advanced
to the point where iliac anatomy is rarely a contraindication to
endovascular repair, the infrarenal neck is often the limiting factor.
There are currently many devices and techniques emerging for
the treatment of “short necks.” The vascular community awaits
a true answer, as “snorkeling” and “surgeon-modiﬁed” devices
have inherent limitations. Other approaches such as sac-
anchoring devices and endostaples have been proposed, but data
remain limited. The most promising devices currently are
“custom-made” and require time for manufacturing. The Ventana
device, as proposed, represents a novel platform for a truly “off-
the-shelf” treatment of juxtarenal and pararenal aneurysms
(potentially including ruptured aneurysms).
Although the data are good, this report describes only 15
patients and has limited follow-up with only eight patients fol-
lowed for more than 6 months. There is the expected 100%technical success rate and the absence of type I and type III endo-
leaks. The clear appeal of the system is the ability to treat numerous
aneurysms effectively with a limited number of conﬁgurations. In
the current series, only four different devices were used to treat
the 15 patients.
There are certain aspects of the Ventana that warrant discus-
sion. The design of the graft, similar to the Endologix Powerlink
infrarenal device, consists of an endoskeleton with the graft mate-
rial freely ﬂoating. This device design ideally allows for greater
conformability and maneuverability of the fenestrations within
the visceral segment. This design is less rigid than the current
custom-made branched devices and allows a limited number of
conﬁgurations to treat numerous anatomies. However, whether
this design will offer durability in the long term remains to be
seen.
The attraction of the Ventana lies in the stepwise advance of
technology to an already receptive audience. The early results are
encouraging. The complexity of the device mandates that this be
used only by specialists with extensive endovascular aneurysm
repair experience. As all the branched and sac-anchoring devices
evolve and data become available, it will be interesting to see where
the Ventana ﬁnds its niche.
